Is Tranexamic Acid Effective For Treating Melasma?

Is Tranexamic Acid Effective For Treating Melasma?

Tranexamic acid is a synthetic derivative of the amino acid lysine that has been used as a topical application, intradermal microinjection, and as an oral agent to treat melasma. Let’s find out how effective is tranexamic acid when dealing with melasma.

Is Tranexamic Acid Effective For Treating Melasma?

There have been many successful treatments with TA in patients with melasma since the 1980s with a significant overall reduction in MASI (Melasma Area and Severity Index) score.

Tranexamic acid inhibits the synthesis of melanin (skin pigment) and the transfer of pigment to the topmost layer of the skin. Since melasma happens when skin cells produce too much melanin, this makes tranexamic acid an ideal way to counteract dark patches on the skin.

Although many scientific studies have shown significant improvement in patients with melasma treated with tranexamic acid, studies have found oral treatments to be more effective at treating melasma than topical or intradermal methods (Wang). In a retrospective review in Singapore, 91.7% of 561 patients who took oral tranexamic acid at a dose of 250 mg twice a day had improvement (Zhang).

Tranexamic acid has not been approved by the FDA for use in the US, and there is still no consensus as to its use (Wang). As a result, tranexamic acid is considered a second-line treatment for melasma that does not respond to first-line treatments such as hydroquinone.

It’s important to remember that both UV and visible light can trigger melasma, so any type of treatment must also include UV protection in order to be effective.

Related:

What Are The Side Effects Of Tranexamic Acid?

In general, tranexamic acid is well tolerated by most patients, meaning that it causes few side effects. However, some side effects are possible.

  • Oral TA: Abdominal pain, nausea, headaches, and depression
  • Topical TA: Skin irritation
  • Injection TA: Pain or swelling at the injection site

Although tranexamic acid is a promising therapeutic agent and causes no significant side effects, hydroquinone remains the gold standard in treatment due to its effectiveness and well-studied effects.

Related:

Is Tranexamic Acid Safe?

According to the results of many meta-analyses, TA is an effective and safe therapy for melasma patients (Palmer). However, more studies are needed to confirm the effectiveness and safety of this type of treatment.

It’s important to consult with your doctor prior to starting a tranexamic acid treatment as this treatment is unsuitable for individuals with certain conditions, including:

Effectively Treat Melasma With ClearifiRx

MELASMA TREATMENT

Custom-Formulated Prescription Cream

One of our world-class dermatologists will formulate a custom prescription cream suited for your unique skin.


Everyone’s melasma is unique, and finding the most effective treatment to manage this condition depends on a variety of factors, including skin type, genetics, sun exposure, and more. ClearifiRx takes the guesswork out of your quest for clear skin. Our board-certified dermatologists consult with you via an online portal and develop a treatment plan that is customized for your skin.

References

Brandon Kirsch, MD
Brandon Kirsch
brandon.kirsch@clearifirx.com

Brandon Kirsch, MD, FAAD, is a board-certified dermatologist specializing in clinical drug development and medical innovation. He is the founder of Kirsch Dermatology in Naples, Florida (www.KirschDerm.com) and is also the Chief of Dermatology at the Naples Community Hospital.

Dr. Kirsch started his career as a lawyer and holds law degrees from the University of Western Ontario (LL.B.) and Georgetown (LL.M. Securities and Financial Regulation). Dr. Kirsch completed his pre-medical studies at the University of Pennsylvania, medical school at Brown University, internship at the Mayo Clinic (Florida) and dermatology residency at the University of North Carolina. In partnership with the Mayo Clinic, he filed to patent a novel topical composition for the treatment of skin hyperpigmentation that he co-developed and also oversaw a successful pilot study of the formulation.

Dr. Kirsch has experience with therapeutic drug development programs from pre-clinical to Phase 3 studies. He is licensed to practice medicine in California, Colorado, Florida, and North Carolina and law in New York and Ontario.



Continue Reading

Recent Posts